Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid (HOCl) products for wound, eye, oral, nasal care, dermatology, and animal health applications. The company's clinically proven products are designed to reduce itch, pain, scarring, and irritation while safely managing skin injuries across 55 countries worldwide.
investor_presentation
23 Pages
investor_presentation
Colfax